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During development, hematopoietic cells originate
from endothelium in a process known as endothe-
lial-to-hematopoietic transition (EHT). To study hu-
man EHT, we coupled flow cytometry and single-cell
transcriptional analyses of human pluripotent stem
cell-derivedCD34+ cells. The resulting transcriptional
hierarchy showed a continuum of endothelial and he-
matopoietic signatures. At the interface of these two
signatures, a unique group of cells displayed both
an endothelial signature and high levels of key he-
matopoietic stem cell-associated genes. This inter-
phase group was validated via sort and subculture
as an immediate precursor to hematopoietic cells.
Differential expression analyses further divided this
population into subgroups, which, upon subculture,
showeddistinct hematopoietic lineage differentiation
potentials.We therefore propose that immediate pre-
cursors to hematopoietic cells already have their
hematopoietic lineage restrictions defined prior to
complete downregulation of the endothelial signa-
ture. These findings increase our understanding of
the processes of de novo hematopoietic cell genera-
tion in the human developmental context.INTRODUCTION
During embryonic development, hematopoietic cells emerge
from a precursor in the endothelial layer lining the ventral side
of the dorsal aorta in the aorta-gonad-mesonephros (AGM) re-
gion. This conversion of endothelium into hematopoietic cells,
termed endothelial-to-hematopoietic transition (EHT), has been
extensively verified in various animal models (Bertrand et al.,
2010; Boisset et al., 2010; Chen et al., 2009; Jaffredo et al.,
1998; Kissa and Herbomel, 2010; Zovein et al., 2008) and has
been observed in live-cell imaging studies of human pluripotent
stem cell (hPSC) differentiation in vitro (Choi et al., 2012; Ditadi
et al., 2015; Rafii et al., 2013). Although EHT was reported in10 Cell Reports 19, 10–19, April 4, 2017 ª 2017 The Authors.
This is an open access article under the CC BY-NC-ND license (http://the human embryo (Oberlin et al., 2002), no detailed molecular
analysis of human cells undergoing EHT has been performed.
Limitations to the study of EHT in human embryos make in vitro
differentiation of hPSCs an attractive model for dissecting this
developmental process. Two independent studies using hPSC
differentiation reported a population enriched for the endothelial
precursor of definitive hematopoiesis, termed hemogenic endo-
thelium (HE), and highlight its transient nature and low frequency
(Choi et al., 2012; Kennedy et al., 2012).
However, the molecular mechanisms regulating de novo
emergence of blood cannot be fully understood until the transi-
tional states in EHT are identified and characterized. Moreover,
murine AGM imaging and transplantation studies show that
while numerous hematopoietic clusters emerge on the walls
of the dorsal aorta, very few of these cells are hematopoietic
stem cells (HSCs) capable of adult multi-lineage reconstitution
(Boisset et al., 2015; Kumaravelu et al., 2002; Taoudi et al.,
2008; Yokomizo and Dzierzak, 2010), indicating heterogeneity
among in vivo emerging blood.
Single-cell transcriptional analysis (reviewed in Hoppe et al.,
2014) is an ideal tool to investigate lineage hierarchies in the het-
erogeneous populations undergoing EHT. Recent single-cell
studies in themouse have identified the onset of a hematopoietic
regulatory program in the early stages of embryonic develop-
ment (Moignard et al., 2015) and characterized a putative HE
population from murine AGM (Swiers et al., 2013). In this latter
study, distinct stages in the EHT process can be visualized for
different populations at successive developmental time-points.
Evaluation of the roles of specific transcription factors (TFs) in
EHT at the single-cell level identified novel players in this process
(Thambyrajah et al., 2016; Wilkinson et al., 2014). Recently, sin-
gle-cell RNA sequencing was used to study the heterogeneity of
prospectively isolated murine populations, including endothelial
cells, pre-HSCs, and HSCs (Zhou et al., 2016).
To characterize EHT in the human developmental context, we
performed single-cell transcriptional analysis of hPSC-derived
CD34+ cells. We identified a rare subset of cells sharing high
numbers of transcripts of both endothelial and hematopoietic
signatures, and determined this EHT subpopulation to be devel-
opmentally betweenHEand newly emerged hematopoietic cells.
Moreover, we demonstrate that hematopoietic lineage differenti-
ation potentials are already restricted in this narrowEHTwindow,creativecommons.org/licenses/by-nc-nd/4.0/).
(legend on next page)
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concurrent with the upregulation of the hematopoietic and down-
regulation of the endothelial programs. Using single-cell analysis,
weprovide further insight into endothelial andhematopoietic line-
age commitment in the human developmental context.
RESULTS
hPSC-Derived CD34+ Fraction Is a Suitable Population
for Single-Cell Transcriptional Analysis of EHT
To dissect human EHT, we used in vitro differentiation of induced
pluripotent stem cells (iPSCs) to the hematopoietic lineage (Ro¨nn
et al., 2015) (Figures 1A and S1A–S1C). Time-course fluores-
cence-activated cell sorting (FACS) analysis for the expression
of HE markers and CD43+ developing hematopoietic cells (Vo-
dyanik et al., 2006) suggested that day 10was an ideal time point
to capture EHT cells (Figure S1D). At this time point, the iPSC-
derived CD34+ fraction contained the CD43CD34hiCD90hi
CD73CXCR4 HE phenotype (10% of CD34+) as well as our
previously described HSC-like phenotype, CD43+CD34+CD90+
(also 10% of CD34+) (Majeti et al., 2007; Ro¨nn et al., 2017) (Fig-
ure 1B). The remaining 80% of cells in the CD34+ fraction include
a broad repertoire of other known human endothelial and he-
matopoietic cells (Ivanovs et al., 2014; Kaufman et al., 2001;
Kennedy et al., 2012; Tavian et al., 1996) and presumably as-
yet-unidentified EHT-related cells.
The hPSC-Derived CD34+ Cell Fraction Contains a
Continuum Spanning Endothelial and Hematopoietic
Transcriptional States, Including a Cell Population with
a Dual Endothelial and HSC Signature
Day 10 iPSC-derived CD34+ cells containing both endothelial
and hematopoietic fractions (CD43-negative and positive cells,
respectively) were index sorted for subsequent single-cell tran-
scriptional analyses (Figure 1C). The iPSC line used had previ-
ously been transduced with a lentiviral vector expressing GFP
under the control of the pan hematopoieticWAS gene promoter
sequences. This WAS-GFP reporter was previously shown to
track early hematopoietic commitment during hPSC differentia-
tion (Mun˜oz et al., 2012) (Figures S1E–S1G). As index sorting al-Figure 1. The hPSC-Derived CD34+ Cell Fraction Contains a Continuum
(A) Overview of iPSC-to-blood differentiation protocol.
(B) FACS analysis of iPSC-to-blood cultures at day 10 of the differentiation proto
(CD34+CD43+CD90+, blue outline) and HE (CD43CD34hiCD90hiCD73CXCR4
(in blue fill and pink fill, respectively, corresponding to the shades in the FACS plo
and red outlines, respectively) within the CD34+ fraction of day 10 iPSC-to-blood
(C) Workflow for single-cell surface marker and transcriptional analysis of CD34+C
were also analyzed for WAS-GFP, CD90, CD73, and CXCR4.
(D) Unsupervised hierarchical clustering, where each group is colored. Second row
genes is color-coded; hematopoietic genes are in blue, endothelial genes are i
endothelium and blood (i.e., implicated in both or none of these two cell types) a
(E) PCA of single cells. Top: cells retrospectively colored by CD43 sorting phenoty
clustering in (D).
(F) Gene loadings of the PCA analysis. Members of the heptad are underlined. Ge
PTPRC, PRDM5, PBX1, MEN1, LIN28B, KCNJ5, HOXA7, HOXA5, HOMER2, HL
(G) Bean plots for the heptad genes included in this analysis.
(H) Bean plots for additional HSC-affiliated genes.
(I) Bean plots for endothelial genes.
Green arrows above bean plots highlight EHT cluster (group 5). See also Figures
12 Cell Reports 19, 10–19, April 4, 2017lows us to determine the FACS phenotype of each transcription-
ally analyzed single cell, the cells were simultaneously analyzed
for WAS-GFP and for CD90, CD73, and CXCR4, the additional
markers relevant in HE and HSC-like phenotypes. As expected,
a fraction of the 437 analyzed CD34+ cells consisted of either HE
or HSC-like cells (Figures S1H and S1I). Expression levels of
91 genes related to endothelium, hematopoietic stem and pro-
genitor cells (HSPCs), as well as EHT were assessed on each
cell (Table S1).
Spanning endothelial and hematopoietic programs, the cells
were divided into ten groups by unsupervised hierarchical
clustering (Figure 1D). Principal-component analysis (PCA)
distributed the cells from nine of the ten groups in a continuum
(Figure 1E). Retrospective coloring based on CD43 sorting
phenotype revealed that hematopoietic and non-hematopoietic
cells grouped separately, with groups 1–5 being almost exclu-
sively CD43 and groups 6–10 being CD43+ (Figures 1D and
1E). No plate-specific bias of independently run qRT-PCR ana-
lyses was seen (Figure S1J), and index-sort data confirmed con-
sistency between protein expression levels of surface markers
and their transcriptional state. Notably, a similar correlation
was observed between the WAS-GFP reporter fluorescence
and WAS transcript levels (Figure S1K).
We proceeded to analyze the identified transcriptional signa-
tures. Groups 2–5 had a clear endothelial program, where group
2 expressed all endothelial genes, and as the hierarchically or-
dered groups proceeded, there was a progressive downregula-
tion of endothelial gene subsets (Figures 1D and S2Ai). Groups
6–8 had a hematopoietic signature, including many genes rele-
vant for HSC function (Figures 1D and S2Aii). Most of these
HSC-affiliated genes were downregulated in groups 9 and 10,
which in turn expressed higher levels of genes associated with
erythro-myeloid maturation (Figures 1D and S2Aiii). Interestingly,
group 5 represented a population at the interface of endothelial
and hematopoietic groups that, in addition to an endothelial
signature, also displayed increased levels of key hematopoietic
genes (green arrow in Figure 1D; see also Figure S2Aiv). Group
1 clustered separately from the transcriptional continuum (Fig-
ures 1D and 1E), lacked expression of most endothelial andof Transcriptional States Spanning Endothelium to Blood
col with gating strategy for the immunophenotypes corresponding to HSC-like
, red outline). Bar graphs show the percentage of CD43+ and CD43 fractions
t), as well as the HSC-like and HE immunophenotypes (in empty columns, blue
cultures (n = 3 independent experiments; data represent mean ± SEM).
D43+/ fractions of day 10 iPSC-to-blood cultures. Using index sort, the cells
: retrospective coloring according to CD43-based sorting. On the left, the list of
n orange, and genes that were not expected to help the distinction between
re in black.
pe. Bottom: cells colored by groups as identified by unsupervised hierarchical
nes in the center of the plot (with loading values close to 0) are ZFP37, RAC1,
F, HIF3A, GPR56, EZH2, ETV2, CDX4, CD38, CCR5, ARID3A, and AKAP5.
S1 and S2 and Table S1.
(legend on next page)
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hematopoietic genes, and expressed genes suggestive of a
mesenchymal cell (Figures 1D and S2Av) (Bakondi et al., 2009;
Lee et al., 2009; Mabuchi et al., 2013; Moignard et al., 2015).
To gain further insight into the gene expression dynamics, we
examined the gene loadings of the PCA and observed a separa-
tion between endothelial and hematopoietic genes. Heptad
complex members (Beck et al., 2013; Wilson et al., 2010) were
distributed in the upper portion of the gene loadings plot
(Figure 1F, genes in underlined font). TAL1, LYL1, GATA2, and
RUNX1 appeared to cluster in the gene loadings plot, suggesting
a cooperation in human EHT, and were notably expressed in
group 5 (Figure 1G). ERG and FLI1were also expressed in group
5 and were clearly defining the endothelial groups, while FLI1
was also expressed in the first hematopoietic groups (Figure 1G).
Other key hematopoietic TFs (e.g., MEIS1, ETV6, GFI1B, and
SPI1) displayed distinct expression patterns in group 5 and sur-
rounding groups (Figure 1H). Finally, two endothelial genes (FLT1
and EFNB2) were both highly expressed in groups 2–5 while be-
ing less expressed or not detected in the hematopoietic groups
6–10 (Figure 1I).
Taken together, we hypothesize that the group 5 cells, at the
interface of the endothelial and hematopoietic programs, are in
a narrow window of the EHT process, just prior to becoming
bona fide hematopoietic cells, and we henceforth designate
this transcriptional cluster as the EHT cluster.
TheEHTCluster andSurrounding Transcriptional States
Identified by Single-Cell qRT-PCR Correspond to
Distinct Endothelial and Hematopoietic Populations as
Assessed by FACS
To elucidate how previously identified FACS-based populations
related to our identified transcriptional groups, we used the in-
dex-sort data for backtracking the surface phenotype of each
analyzed cell. We observed that cells with the HSC-like immuno-
phenotype were predominantly found downstream of the EHT
cluster, with groups 6 and 7 (Figure 2A) showing highest expres-
sion levels of HSC-affiliated genes (Figures 1D, 1G, and 1H). We
also observed that HE cells were found scattered throughout
groups 2 to 5 (highest in group3), indicating heterogeneity of
this immunophenotype. Cells corresponding to arterial and
venous endothelium as described in Ditadi et al. (2015) were
found almost exclusively in group 2 (Figure 2A).Figure 2. The Different Transcriptional Groups Identified by Single-Cel
(A) Distribution, throughout the ten transcriptional groups identified in Figure 1D,
(using index-sort data) stated on the left.
(B) Scatterplot of the single cells according to surface expression of CD34 and
transcriptional group they belong to. Putative FACS gates were drawn to enrich for
log10.
(C) FACS phenotype characterization of transcriptional group 5. Expression leve
remaining cells are in gray. Fluorescence intensity in log10.
(D) Validation of putative gates drawn in (B). Below, the color of the frame of the pl
CD43 FACS plot. Plots are representative of two to four independent experimen
(E) Bean plots from the transcriptional analysis of Figure 1, the transcripts of the
(F) Gating strategy for sorting the CD43+CD34+ identified subpopulations corresp
committed cells (purple).
(G) CFU counts per 100 plated cells sorted using the gating strategy outlined in
(H) CFU counts per 100 plated cells sorted using the gating strategy outlined in (
Data represent mean ± SEM; n = 2 independent experiments.
14 Cell Reports 19, 10–19, April 4, 2017We then used the index-sort data to define sortable populations
of EHT cluster cells and of other identified transcriptional states
and observed that the different transcriptional groups already
clustered indistinctpopulationsbasedonCD34andCD43surface
expression (Figure 2B). Specifically, the CD43CD34hi population
enriched for the vascular endothelium (group 2), CD43CD34int
enriched for HE cells (groups 3 and 4), CD43+CD34hi enriched
for HSC-like transcriptional signature (groups 6 and 7), and
CD43+CD34low enriched for the erythro-myeloid-committed
signature (groups 9 and 10) (Figure 2B). Interestingly,weobserved
that the EHT cluster localized mostly at the interface between the
CD43 and CD43+ populations (Figure 2B, large green dots).
These EHT cluster cellswere almost exclusively CD90hi, CXCR4,
and CD73 and contained bothWAS-GFP andWAS-GFP+ cells
(Figure 2C). This enrichment strategy and the endothelial and
hematopoietic cell identities of the transcriptional groups were
confirmed by FACS analyses in additional independent experi-
ments (Figure 2D). Notably, the transcript and protein levels as as-
sessed by FACS for new surface markers were highly correlated
and similarly up- or downregulated in the corresponding groups,
including theWAS-GFP reporter andendogenousWAS transcript,
whose expression was initiated in some cells within the EHT clus-
ter and increased in thehematopoietic groups (Figures2Dand2E).
Interestingly,glycophorinA (GYPA)expressionwasalso initiated in
the EHT cluster. Moreover, sorting the identified transcriptional
groups (EHT cluster, HSC-like, and erythro-myeloid committed
cells) and plating into a colony-forming unit (CFU) assay revealed
differences in both colony numbers and subtypes, demonstrating
functional differences between the populations (Figures 2F–2H).
The EHT Transcriptional Cluster Comprises Subgroups
with Distinct Levels of Hematopoietic Commitment Both
Transcriptionally and in Differentiation Potential
To further dissect EHT, we performed a new single-cell qRT-PCR
analysis on EHT cluster-enriched cells (CD43intCD34+CD90hi)
(Figure 3A). Combining this expression data with that of the
initially sortedmaterial increased the complexity of the EHT clus-
ter, which could then be divided into three subgroups by hierar-
chical clustering (Figure 3B). These subgroups had progressively
increased expression of a subset of hematopoietic genes,
including endogenousWAS,GFI1B, andETV6 (Figure 3C). These
differences correlated with a progressive increase in CD43l Analysis Correspond to Distinct Populations as Assessed by FACS
of the single cells displaying the previously characterized surface phenotypes
CD43 using index-sort data. The single cells are colored according to the
the transcriptional groups stated in the legend below. Fluorescence intensity in
ls for cells belonging to group 5 EHT cluster cells are in dark green, and the
ots displays their correspondence to the gate of same color in the above CD34/
ts.
surface proteins analyzed in (D).
onding to EHT cluster (outlined in green), HSC-like (blue), and erythro-myeloid-
(F).
F), with average representation of colony subtypes.
(legend on next page)
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surface expression and in the WAS-GFP reporter expression
(Figure 3D), suggesting that the originally identified EHT cluster
contained cells with different levels of hematopoietic commit-
ment. We therefore sought to elucidate if sorted WAS-GFP
andWAS-GFP+ EHT cluster cells would exhibit different hemato-
poietic potentials.
We sorted EHT cluster cells (CD34+CD43intCD90hiCD73)
separating WAS-GFP (EHT-GFP) from WAS-GFP+ (EHT-
GFP+) fractions for subculture assays (Figures 3E and S3A–
S3C). These EHT cluster sorted populations displayed cells
of both spindle-shapedendothelial and roundhematopoieticmor-
phologies 2 days after plating (Figure 3F). Tracking WAS-GFP
expression in the cultured EHT fractions, we observed instances
of WAS-GFP+ cells with endothelial morphology, including from
EHT-GFP sorted cells (Figure S3D, arrowheads). Surfacemarker
analysis revealed high frequency of hematopoietic cells from both
these sorted fractions by day 5 (Figure 3G). In comparison, the
CD34int HE sorted cells had exclusively endothelial morphology
shortly after plating (day 2) and developed round hematopoietic
cells by day 5 of subculture. As expected, theHSC-like population
subculture resulted almost exclusively in blood cells and no endo-
thelial progeny (Figures 3F–3H). Interestingly, therewas increased
blood/endothelium ratio from the analyzed populations the more
transcriptionally committed they were toward the hematopoietic
fate (Figures 3G and 3H, left).
These results confirm enrichment for cells undergoing EHT in
the EHT-cluster-sorted populations and suggest a develop-
mental progression within the EHT cluster.
The EHT Cluster Subpopulations Possess Distinct and
Overlapping Hematopoietic Development Markers and
Lineage Potentials
To evaluate the hematopoietic differentiation potentials of the
above EHT-related populations, we analyzed the hematopoietic
(CD43+) fraction resulting from the 5-day-subcultured cells for
the expression of CD45 (as an indicator of developmental pro-
gression within hematopoietic ontogeny), CD41a and GYPA (as
indicators of erythro-myeloid lineage commitment), and CD34
as a marker of progenitors. The HSC-like population gave rise to
blood cells with all combinations of CD45/CD41a immunopheno-
types, suggesting a broad repertoire of developmentally distinct
and lineage committing hematopoietic cells (Figures 3G and 3H,Figure 3. Differentiation Potential of the Identified EHT Transcriptiona
(A) Gating strategy enriching for the EHT cluster.
(B) Top: hierarchical clustering integrating EHT-cluster-enriched cells together wi
three subgroups identified within the EHT cluster.
(C) Expression levels of genes upregulated along the three EHT cluster subgroup
(D) CD43 surface expression and WAS-GFP levels detected by FACS (using the
(E) Sorting strategy used for subculturing populations enriched for CD34int HE, E
scriptional groups.
(F) Phase-contrast pictures of sorted cells during subculture. Day 2 corresponds
analysis. Scale bar, 100 mm.
(G) FACS analysis of day 5 sub-cultures, corresponding to the micrographs in the
(H) Left: endothelial progeny per 100 plated cells. Right: stacked bar graph of the
represent mean ± SEM; n = 3 independent experiments.
(I) Pie charts representing the average composition, in three independent exper
population. Each color corresponds to each population resulting from all CD45,
See also Figure S3.
16 Cell Reports 19, 10–19, April 4, 2017right). However, the progeny of EHT-GFP+, the closest EHT clus-
ter population according to gene expression, was almost exclu-
sively CD45+, suggesting a developmentally more mature he-
matopoietic progression (Figures 3G and 3H, right). The more
distant EHT-GFP cells had a progeny very similar to that of
HSC-like cells, suggesting EHT-GFP cells to be full contributors
to all developmental stages and committed lineages from the
HSC-like fraction. Analyzing GYPA further confirmed the similar-
ities between theHSC-like andEHT-GFP cells; both are capable
of generating an early-committing erythroid lineage cell, but the
EHT-GFP+ sorted fraction did not have this potential (Figure 3I,
red dataset in pie charts). This suggests that the EHT-GFP cells
possess a broader hematopoietic differentiation potential, gener-
ating more developmentally immature CD45 as well as GYPA+
cells, as compared to theEHT-GFP+ cells. These results also indi-
cate that hematopoietic lineage differentiation potential is already
defined prior to complete downregulation of the endothelial pro-
gram during EHT.
We then set out to combine this differentiation potential data
with gene expression correlation analysis in order to infer lineage
relationships between the identified transcriptional groups (Fig-
ure 4A). We observed high correlation coefficients within the
endothelial groups 2–5, hematopoietic groups 6–8, and mature
hematopoietic groups 9 and 10. We then combined this with
the index-sort data and differentiation potential assays to pro-
pose a model with the different transcriptional states identified
in the hPSC-derived CD34+ population as well as lineage rela-
tionships using gene expression correlation as well as validation
through subculture (Figure 4B).
DISCUSSION
Using qRT-PCR analysis of index-sorted hPSC-derived CD34+
single-cells enabled molecular characterization of transcrip-
tional states throughout human EHT as well as the identification
and sorting of populations of cells undergoing this process that
upon culture possess differing hematopoietic lineage poten-
tials. Our results show heterogeneity of the cells undergoing
EHT, as they downregulate their endothelial programs and upre-
gulate their hematopoietic programs. The EHT cluster could
be subdivided based on increasing expression of eight genes,
including GFI1B, shown in the murine system to be a key playerl States
th overall analysis of CD34+ cells. Bottom: heatmap of gene expression for the
s identified in (B).
index-sort data) in the three EHT cluster subgroups identified in (B).
HT cluster further divided in WAS-GFP and WAS-GFP+, and HSC-like tran-
to the day following aggregate plating; day 5 is the day of harvest for FACS
same rows in (F). Plots are representative of three independent experiments.
CD41a/CD45 hematopoietic progeny resulting from each subpopulation. Data
iments, of the CD43+ blood fraction at the end of subculture for each sorted
CD41a, CD34, and GYPA surface marker combinations.
Figure 4. Inferring Population Hierarchy Us-
ing Single-Cell Analysis
(A) Pearson’s correlation analysis calculated with
the average expression values for each gene within
each group. FACS-sorted populations, listed on
the right, correspond to visibly correlating clusters.
(B) Combining differentiation potential assay and
Pearson’s correlation data to infer lineage re-
lationships between the identified groups. Groups
are placed according to their CD34/CD43 pheno-
type. Black connections correspond to Pearson’s
correlation between groups with R > 0.8 (thickness
proportional to R value). Red arrows summarize
lineage relationships confirmed (solid arrows) or
inferred (dashed arrows) from the differentiation
potential assay.for the loss of endothelial identity during EHT (Lancrin et al.,
2012) and for hematopoietic maturation within AGM cells under-
going EHT (Thambyrajah et al., 2016). TheWAS-negative (EHT-
GFP) cells within this EHT population displayed the broadest
hematopoietic lineage potential similar to that of the HSC-like
population, while the WAS-expressing (EHT-GFP+) fraction
gave rise to a more restricted hematopoietic progeny, almost
exclusively CD45+, with no GYPA+ cells. This led us to propose
that the hematopoietic differentiation potential in the develop-
mental context is already determined within unique cell popula-
tions at the EHT stage. This also implies that separate outcrops
of hematopoietic cells emerge from EHT subsets with different
lineage propensities depending on the expression levels of
specific hematopoietic genes. In support of our findings, a
recent study of murine AGM pre-HSCs also demonstrates het-
erogeneity during emergence at the single-cell level (Zhou
et al., 2016). The heterogeneity within EHT could allow for yet
another level of control of hematopoietic lineage contributions
during development.
TheCD34intHEpopulation is enriched in transcriptional group3,
themost abundant transcriptional group in the cells displaying the
immunophenotype corresponding to that of previously character-
ized HE (Ditadi et al., 2015). Interestingly, among the endothelial
transcriptional groups, group 3 had specifically high expressionof genes, including a subset of hematopoi-
etic TFs and epigenetic modifiers (see Fig-
ure S2Avi). These genesmay be part of the
regulatory network conferring hemogenic
capacity to these cells. The hematopoietic
progeny of this CD34intHE subset con-
tained similar populations as that of EHT
cluster and HSC-like fractions (albeit with
different frequencies), with nearly every
CD45+ cell co-expressingCD34 (Figure3I).
This suggests that CD34intHE population
may give rise to the EHT cluster and
HSC-like populations (from which only a
small subset of resulting CD45+ cells co-
expressed CD34).
Expression dynamics of the analyzed
heptad members suggested a patternwith cooperation of TAL1, LYL1, GATA2, and RUNX1 and sepa-
rate activity of FLI1 and ERG. This corroborates a recent study
showing stronger correlation between TAL1, LYL1, GATA2,
and RUNX1 in terms of DNA-binding patterns, with FLI1 and
ERG displaying a separate binding partnership (Wilson et al.,
2016). The first four TFs have been shown to synergize for
HSC emergence in the murine setting (Chan et al., 2007; Chen
et al., 2009; Nottingham et al., 2007), and it is therefore plausible
that they also cooperate during human EHT.
Our approach of profiling a heterogeneous subset of cells at
the single-cell level proved here to be highly useful to dissect
sequential transcriptional states during human EHT. It can be
applied to the study of primary material from developing human
tissues to decipher the molecular mechanisms of human EHT
in vivo and ultimately generate transplantable HSCs in vitro.
Our findings set the stage for further exploration of heterogeneity
during human hematopoietic cell emergence.
EXPERIMENTAL PROCEDURES
iPSC Expansion and Differentiation
The human iPSC-CB1RB9 cell line was expanded and differentiated toward
the hematopoietic lineage as described previously (Ro¨nn et al., 2015) (see
Supplemental Experimental Procedures). Briefly, mesoderm-biased embryoid
bodies were generated and plated on extracellular matrix to develop anCell Reports 19, 10–19, April 4, 2017 17
endothelial-like cell monolayer, from which presumptive hematopoietic cells
emerge. Mesototal medium (Primorigen Biosciences) was applied throughout
the procedure.
Single-Cell qRT-PCR
At day 10 of the differentiation protocol, the cells were harvested and
stained as described in Supplemental Experimental Procedures. Single
CD34+ cells were sorted directly into lysis buffer using the index-sorting
function of the Diva Software. Target-specific pre-amplification mastermix
was then added to each sample for reverse transcription (RT) and pre-ampli-
fication. Pre-amplified samples were diluted and analyzed in Fluidigm 96.96
arrays on a Biomark device (Fluidigm), with the TaqMan assays listed in
Table S1. For further details and reagents, see Supplemental Experimental
Procedures.
Single-Cell qRT-PCR Data Analysis
The data were first analyzed with Fluidigm Real-Time PCR Analysis Software
for evaluation of the amplification curves, and Ct thresholds were set automat-
ically using the ‘‘auto detector’’ function. Reactions with Ct > 30 were consid-
ered negative. In assays where amplification was detected in no-RT controls,
all reactions displaying Ct > [min(CtnoRTcontrols) 2] were considered negative.
The data were then analyzed using the SCexV online tool (http://stemsysbio.
bmc.lu.se/SCexV/; Lang et al., 2015), together with the index-sort data, for
performing PCA and hierarchical clustering based on the gene expression
data. Cells displaying a Ct value > 25 in the housekeeping gene GAPDH
were excluded from the analysis, as well as the positive control samples. Sub-
sequent analysis was then performed for the remaining cells (representing over
90% of the total sorted cells), using Z score transformed expression data of all
assays excluding the housekeeping gene GAPDH. Unsupervised hierarchical
clustering results were used for defining the groups of interest.
Subculture Assay
At day 10 of iPSC-to-blood differentiation, the indicated populations were
sorted and cultured in an assay adapted from Ditadi and Sturgeon (2016).
Specifically, the sorted cells aggregated overnight in ultra-low adherence
U-shaped-bottom 96-well plates, and aggregates were then transferred onto
Matrigel-coated flat-bottom 96-well plates. At 5 days post-sort, the cells
were collected and analyzed by FACS. For details, see Supplemental Experi-
mental Procedures.
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